ZYME: Zymeworks BC Inc Company Profile & Statistics

About

Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.

Info & Links

CEO

Kenneth Galbraith

Headquarters

108 PATRIOT DRIVE, SUITE A
MIDDLETOWN, DE 19709, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

277

Zymeworks BC Inc Statistics

Valuation Measures

Market Capitalization²

918.86M

Enterprise Value

796.50M

Enterprise Value/EBITDA(ttm)

-5.92

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

13.93

Price to Book(mrq)

2.36

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-112.25%

Operating Margin(ttm)

-154.96%

Profit Margin(ttm)

-195.89%

Return on Equity(ttm)

-23.00%

Return on Invested Capital(ttm)

-27.76%

Return on Assets(ttm)

-18.04%

Income Statement

Revenue(ttm)

62.20M

Revenue Per Share(ttm)

0.90

Gross Profit(ttm)

-60.88M

EBITDA(ttm)³

-134.60M

Net Income Available to Common(ttm)

-113.67M

Diluted EPS(ttm)

-1.50

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

44.53%

S&P 500 52-Week Change

27.63%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

68.88M

Dividend Yield

0.00%

Float⁴

67.56M

% Held by Insiders

1.92%

% Held by Institutions

92.89%

Balance Sheet

Total Cash(mrq)

297.20M

Total Cash Per Share(mrq)

4.31

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.10%

Quick Ratio(mrq)

4.10%

Book Value Per Share(mrq)

5.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.90

Free Cash Flow(ytd)

-70.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ZYME

Zymeworks BC Inc

Zymeworks BC Inc Profile